Intramyocellular diglycerides have been implicated in the development of insulin resistance. We aimed to evaluate the effect of weight loss, a well-known means for the improvement of insulin resistance, on intramyocellular diglycerides and triglycerides in type II diabetes. Participants were five obese women with type II diabetes (body mass index 37.5±1.9 kg/m 2 ), who participated in a weight loss program. The aim of the program was a reduction in body weight by 10%. Muscle biopsies were obtained before and after weight loss. The intervention induced a marked reduction in intramyocellular triglycerides by 77.7±13.1%, whereas no significant differences were observed for diglycerides before and after weight loss. Our results indicate that weight loss due to negative energy balance depletes intramyocellular lipid storage without affecting intermediate molecules of lipid metabolism, such as intramyocellular diglycerides.
Introduction
Weight loss has been established as a fundamental approach in the prevention and treatment of diabetes mellitus; however, the underling mechanisms of increased insulin sensitivity and improved glycemic control after weight loss remain unclear. As intramyocellular lipid content has been directly linked to insulin resistance in diabetes-prone individuals (Perseghin et al., 1999) , a potential candidate of enhanced insulin action after weight loss could be a reduction in the lipid content of skeletal muscle. Nevertheless, studies examining the effect of moderate weight loss on intramyocellular lipids in subjects with type II diabetes have produced controversial results, showing either a reduction (Goodpaster et al., 2000) or no change at all (Tamura et al., 2005) . Advanced molecular studies have implicated intramyocellular lipid partitioning, rather than total lipids, in the pathophysiology of diabetes. In particular, it has been proposed that some intermediate molecules of lipid metabolism (that is, diglycerides), and not total lipid storage, may be implicated in insulin resistance through their impact on insulin signaling (Nishizuka, 1995) .
The aim of the present study was to explore changes in intramyocellular lipid pools (triglycerides and diglycerides) in response to moderate weight loss in type II diabetes mellitus.
Subjects and methods
Five post-menopausal, sedentary female obese subjects with type II diabetes (age: 51.6 ± 3.0 years, body mass index 37.5 ± 1.9 kg/m 2 ) participated in the study. Subjects were prescribed a hypocaloric diet (deficit of 500-700 kcal per day of estimated energy needs for weight maintenance, 50-55% of total energy as carbohydrates, 15-20% as dietary protein and 30% as fat) and were followed up on weekly sessions until the end of the intervention. The goal of the program was a weight reduction of 10% of initial body weight, irrespective of the time needed from each participant to achieve this goal. Energy needs were calculated as the basal metabolic rate multiplied by a suitable physical activity level (Shetty et al., 1996) . Basal metabolic rate was measured by open circuit indirect calorimetry. The study was conducted according to the standards set by the latest version of the Declaration of Helsinki and was approved by the University Review Board. A written informed consent was obtained from each participant. Diabetic medication (sulfonylureas or metformin) was not altered and remained unchanged throughout the intervention. A standard oral glucose tolerance test was performed and a needle muscle biopsy from the vastus lateralis muscle was obtained before and after weight loss. Post intervention measurements were performed at the time the weight loss goal was achieved for each participant, when they were still on the prescribed diet. The total area under the glucose curve and the homeostatic model (homeostasis model assessment of insulin resistance, HOMA-IR) (Matthews et al., 1985) were used for the assessment of glycemic control and insulin resistance, respectively. Baseline blood lipid profile before and after weight loss was also assessed. Intramyocellular lipids were measured as recently described (Anastasiou et al., 2009) . In brief, triglycerides and diglycerides were separated by solid-phase extraction, their fatty acids were transmethylated and fatty acid methyl esters were quantified by gas-liquid chromatography. Fatty acids contained in each lipid class were categorized on the basis of the degree of saturation. Total triglycerides and diglycerides were calculated by dividing the sum of the molar concentrations of methyl esters by three and two, respectively. To avoid contamination from fat tissue, muscle specimens were freeze-dried and connective or fat tissue was removed after careful examination under magnification on a stereoscope. Blood biochemical analyses were performed in duplicate in an automated analyzer using standard reagents (ACE Schiapparelli Biosystems, Fairfield, NJ, USA). Insulin was measured in triplicate by an enzyme-linked immunoassay (Insulin; DakoCytomation, Glostrup, Denmark). The total area under the glucose curve was calculated by the trapezoid rule and HOMA-IR by the equation:
where [Insulin] and [Glucose] are fasting values of insulin and glucose in mU/l and mmol/l, respectively. Data are presented as means ± 1 standard error of the mean. Comparisons before and after weight loss were performed by the two-tailed Wilcoxon non-parametric test.
Results and discussion
The intervention resulted in a À9.5±0.6% weight loss (101.8 ± 5.8 vs 92.0 ± 4.9 kg before and after weight loss, respectively, Po0.05) and had a duration range from 17 to 32 weeks. A significant improvement in glucose control indices was observed after weight loss, accompanied by a non-statistically significant, but noteworthy reduction in HOMA-IR (P ¼ 0.08) ( Table 1) . The intervention had a small positive impact in blood lipid profile, except a significant decrease in high-density lipoprotein. Figure 1 presents intramyocellular lipids and their fatty acid residues before and after weight loss. A remarkable decrease by 77.7±13.1% in intramyocellular triglyceride content was observed (Po0.05). Similar decreases were observed in all triglyceride fatty acid residues (that is, saturated, monounsaturated and poly-unsaturated fatty acids). Changes in intramyocellular diglycerides before and after weight loss did not show a uniform pattern with three negative and two positive ranks. Mean values before and after weight loss were 8.25±1.71 vs 5.91±0.76 nmol/mg dry tissue (change in range, À6.24 to 2.41) and changes were not significantly different (P ¼ 0.686).
Our results reveal that moderate weight loss depletes intramyocellular lipid storage, without significantly affecting diglyceride levels in diabetes mellitus. The marked decrease in intramyocellular triglycerides may be attributed to the fact that subjects at the end of the protocol were still on a hypocaloric diet. To this perspective, it is not clear whether the observed reduction may be attributed to the weight loss per se or it was the effect of negative energy balance. However, even under these conditions, no such clear effect was observed for intramyocellular diglycerides. A reduction of the overall flux to lipid uptake and esterification at fasting that has been observed after weight loss (Kelley et al., 1999) , along with a modest reduction in the availability of substrates from the systemic circulation, may explain at least in part the depletion of intramyocellular lipid storage, without affecting intermediate molecules of lipid metabolism, such as diglycerides. In this perspective, the well-known effects of weight loss on insulin sensitivity and glucose homeostasis may not be mediated by changes in these intermediate molecules. 
